These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 29534065)

  • 61. Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.
    Gao W; Chan JY; Wong TS
    Clin Sci (Lond); 2014 Nov; 127(9):571-9. PubMed ID: 24896104
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
    Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
    BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients.
    Eldosoky MA; Hammad R; Elmadbouly AA; Aglan RB; Abdel-Hamid SG; Alboraie M; Hassan DA; Shaheen MA; Rushdi A; Ahmed RM; Abdelbadea A; Abdelmageed NA; Elshafei A; Ali E; Abo-Elkheir OI; Zaky S; Hamdy NM; Lambert C
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834570
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
    Wong QW; Lung RW; Law PT; Lai PB; Chan KY; To KF; Wong N
    Gastroenterology; 2008 Jul; 135(1):257-69. PubMed ID: 18555017
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
    He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
    PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosis.
    Wang Z; Ding Q; Li Y; Liu Q; Wu W; Wu L; Yu H
    Tumour Biol; 2016 Nov; 37(11):14779-14787. PubMed ID: 27633066
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB2.
    Jiang G; Wen L; Deng W; Jian Z; Zheng H
    Biomed Pharmacother; 2017 Jun; 90():806-812. PubMed ID: 28437884
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An Explorative Analysis for the Role of Serum miR-10b-3p Levels in Predicting Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
    Yoon EL; Yeon JE; Ko E; Lee HJ; Je JH; Yoo YJ; Kang SH; Suh SJ; Kim JH; Seo YS; Yim HJ; Byun KS
    J Korean Med Sci; 2017 Feb; 32(2):212-220. PubMed ID: 28049231
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs.
    Selitsky SR; Dinh TA; Toth CL; Kurtz CL; Honda M; Struck BR; Kaneko S; Vickers KC; Lemon SM; Sethupathy P
    mBio; 2015 Dec; 6(6):e01500-15. PubMed ID: 26646011
    [TBL] [Abstract][Full Text] [Related]  

  • 71. miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature.
    Fittipaldi S; Vasuri F; Bonora S; Degiovanni A; Santandrea G; Cucchetti A; Gramantieri L; Bolondi L; D'Errico A
    Dig Dis Sci; 2017 Sep; 62(9):2397-2407. PubMed ID: 28639131
    [TBL] [Abstract][Full Text] [Related]  

  • 72. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
    Zhao J; Xu T; Wang F; Cai W; Chen L
    Biomed Pharmacother; 2017 Jun; 90():744-751. PubMed ID: 28419971
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
    Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
    Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
    [TBL] [Abstract][Full Text] [Related]  

  • 74. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MicroRNA-125a-5p Is a Downstream Effector of Sorafenib in Its Antiproliferative Activity Toward Human Hepatocellular Carcinoma Cells.
    Potenza N; Mosca N; Zappavigna S; Castiello F; Panella M; Ferri C; Vanacore D; Giordano A; Stiuso P; Caraglia M; Russo A
    J Cell Physiol; 2017 Jul; 232(7):1907-1913. PubMed ID: 27982429
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma.
    Zheng J; Dong P; Gao S; Wang N; Yu F
    Hepatogastroenterology; 2013 May; 60(123):549-52. PubMed ID: 23108086
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Extract of Stellerachamaejasme L(ESC) inhibits growth and metastasis of human hepatocellular carcinoma via regulating microRNA expression.
    Liu X; Wang S; Xu J; Kou B; Chen D; Wang Y; Zhu X
    BMC Complement Altern Med; 2018 Mar; 18(1):99. PubMed ID: 29554896
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Roles of miR-590-5p and miR-590-3p in the development of hepatocellular carcinoma].
    Yang H; Zheng W; Zhao W; Guan C; An J
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):804-11. PubMed ID: 23803188
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long non-coding RNA Fer-1-like protein 4 acts as a tumor suppressor via miR-106a-5p and predicts good prognosis in hepatocellular carcinoma.
    Wu J; Huang J; Wang W; Xu J; Yin M; Cheng N; Yin J
    Cancer Biomark; 2017 Jul; 20(1):55-65. PubMed ID: 28759956
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
    Zhang C; Xia R; Zhang B; Wang H
    BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.